Here are five things to know:
1. The company issued 504,538 common shares at $1.35 per share.
2. The aggregate gross proceeds are CDN $681,126.
3. Proceeds from the offering will be used for general working capital purposes.
4. Director James Snow directly or indirectly subscribed for 84,444 common shares under the offering; Director David Rosenkrantz subscribed to 112,000.
5. The common shares issued under the offering are subject to a four-month hold period expiring May 10, 2015.
More articles on orthopedic devices:
8 trends in the biocompatible materials market
K2M revenue up 18% in 2014—5 things to know
Could Congress repeal the medical device tax without Obama? 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
